Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants

Kidney International

Volumn 71, Issue 5, 2007, Pages 425-430

  Solid, C A ^a   Foley, R N ^a,b   Gill, J S ^c   Gilbertson, D T ^a   Collins, A J ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anemia; Epoetin; Hemoglobin; K DOQI guidelines; Renal dialysis; Renal transplant

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RENAL REPLACEMENT THERAPY; RISK; SURVIVAL; TREATMENT FAILURE; UNITED STATES;

ADOLESCENT; ADULT; ANEMIA; EPOETIN ALFA; GRAFT REJECTION; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 33847198948     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002056     Document Type: Article

References (18)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. De Nour AK, Shanan J. Quality of life of dialysis and transplanted patients. Nephron 1980; 25: 117-120.
3. Evans RW, Manninen DL, Garrison Jr LP et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-559.
4. Churchill DN, Torrance GW, Taylor DW et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10: 14-20.
5. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: a reexamination. Am J Kidney Dis 1989; 13: 200-209.
6. Simmons RG, Anderson CR, Abress LK. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol 1990; 131(Suppl): 7-22.
7. Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
8. Jofre R, Lopez-Gomez JM, Moreno F et al. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998; 32: 93-100.
9. Fujisawa M, Ichikawa Y, Yoshiya K et al. Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology 2000; 56: 201-206.
10. Gross CR, Limwattananon C, Matthees B et al. Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 2000; 70: 1736-1746.
11. Akman B, Ozdemir FN, Sezer S et al. Depression levels before and after renal transplantation. Transplant Proc 2004; 36: 111-113.
12. Organ Procurement and Transplantation Network. available at: http://www.optn.org, accessed 27 March 2006.
13. Foley RN, Li S, Liu J et al. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2005; 16: 210-218.
14. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30: S192-S240.
15. Kaplan B. Herwig-Ulf Meier-Kriesche. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002; 2: 970-974.
16. Almond MK, Tailor D, Marsh RP et al. Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant 1994; 9: 270-273.
17. Vanrenterghem Y. Anaemia after renal transplantation. Nephrol Dial Transplant 2004; 19(Suppl 5): V54-V58.
18. Thamer M, Zhang Y, Kaufman J et al. Factors influencing route of administration for epoetin treatment among hemodialysis patients in the United States. Am J Kidney Dis 2006; 48: 77-87.